Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Abstract For most patients with acute myeloid leukemia (AML), an allogeneic hematopoietic stem cell transplantation (HSCT) offers the highest chance of cure. Recently, the European LeukemiaNet (ELN) published updated recommendations on the diagnosis and risk classification in AML based on genetic fa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H. Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Publishing Group 2022-12-01
coleção:	Blood Cancer Journal
Acesso em linha:	https://doi.org/10.1038/s41408-022-00764-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!